October 31, 2019
Quacell Biotechnology won the Top 50 of Innovative Biotechnology Enterprises in Guangdong-Hong Kong-Macau Greater Bay Area
On October 16th, in Guangzhou, the 2nd Edition Guangdong-Hong Kong-Macau Greater Bay Area Biotechnology Innovation Development Summit & Award Ceremony of Top 50 Biotechnology Innovation Enterprises in Guangdong-Hong Kong-Macau Greater Bay Area awarded Quacell Technology the honor of Potential Enterprise.
Sponsored by KPMG China and the CIC Research Institute, this selection event aimed to discover unicorn companies in the Biotechnology Industry and cultivate an innovative ecology integrating production, education, and research in Guangdong-Hong Kong-Macau Greater Bay Area.
Adopting the Big Data Innovation Standard System, the selection focused on three significant companies: Medical Devices, Biomedicine and Technology, and Medical Services. To select Leading Enterprise, Pioneer Enterprise, New enterprises, and Potential enterprises, leading teams of experts spent six months to conduct field visits and have face-to-face discussions with companies in Guangdong-Hong Kong-Macau Greater Bay Area.
Dr. Poon, CEO of QuaCell Biotechnology, Co., Ltd. was honored to be elected Associate Editor of RE: GEN Open
Conclusion | Biofuture2021
BIG EVENETS. Day 2 | Biofuture 2021
BIG EVENETS. Day 1 | Biofuture 2021
Wayne293™ Transient medium was launched